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ABSTRACT
Many kinases are still ‘orphans,’ which means knowledge about their substrates,
and often also about the processes they regulate, is lacking. Here, DIA1/C3orf58,
a member of a novel predicted kinase-like family, is shown to be present in the
endoplasmic reticulum and to influence trafficking via the secretory pathway.
Subsequently, DIA1 is subjected to phosphoproteomics analysis to cast light on
its signalling pathways. A liquid chromatography–tandem mass spectrometry
proteomic approach with phosphopeptide enrichment is applied to membrane
fractions of DIA1-overexpressing and control HEK293T cells, and phosphosites
dependent on the presence of DIA1 are elucidated. Most of these phosphosites
belonged to CK2- and proline-directed kinase types. In parallel, the proteomics
of proteins immunoprecipitated with DIA1 reported its probable interactors.
This pilot study provides the basis for deeper studies of DIA1 signalling.
Subjects Bioinformatics, Cell Biology, Molecular Biology
Keywords Phosphoproteomics, Novel kinases, Signalling, Secretory pathway, Mass spectrometry
INTRODUCTION
Protein kinase-like (PKL) proteins are a very large group of signalling and biosynthetic
enzymes, that regulate most cellular processes, for example cell cycle, response to
stimuli, and proliferation, by phosphorylating various substrates (Cohen, 2002) and are
common in all branches of the tree of life (Kannan et al., 2007; Oruganty et al., 2016). The
human genome encodes more than 500 protein kinases (Manning et al., 2002), and these
proteins are among the most popular drug targets (Eglen & Reisine, 2011). According
to the Pfam database, the PKL ‘clan,’ defined by sequence and structure similarities
reflecting common evolutionary origin, includes 35 protein families (Finn et al., 2016).
Nevertheless, this number is still growing, as more families are found to possess PKL
three-dimensional fold, for example FAM20C (Tagliabracci et al., 2012) and COTH
(Nguyen et al., 2016), or are predicted to be PKL-like (Dudkiewicz et al., 2012). The PKL
proteins are characterised by a well-conserved structural scaffold, which carries a strongly
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conserved active site (Cheek et al., 2005; Taylor & Radzio-Andzelm, 1994), although
within the PKL clan, sequence similarities between some families are rather low.
Notwithstanding the high level of interest in kinases, research effort has been strongly
biased (Edwards et al., 2011; Manning, 2009) with approximately 10% of known human
kinases yielding at least 90% of kinase-related publications (Edwards et al., 2011). An
important fraction (approximately 10%) of the PKL superfamily are proteins termed
pseudokinases. These are homologues of kinases that have lost catalytic function but often
have retained important roles in signalling, for example as allosteric activators of active
kinases (Jacobsen & Murphy, 2017).
Although protein kinases were originally believed to act intracellularly, secretory
kinases form an emerging novel addition to the PKL world (Sreelatha, Kinch &
Tagliabracci, 2015; Tagliabracci et al., 2012, 2015). In humans, the kinase-like proteins
related to the secretory pathway are likely far from being fully catalogued. The now
established atypical protein kinases, FAM20s, localised in the Golgi apparatus, are secreted
and phosphorylate secretory pathway proteins (Ishikawa et al., 2008; Koike et al., 2009;
Tagliabracci et al., 2012). Nevertheless, FAM20C is not the only secretory kinase in bone,
an organ where secretion is very important (Yang et al., 2016) which suggested that
generally more secretory kinases may be at play in humans. Another secretory protein
kinase, the PKDCC, was characterised earlier (Bordoli et al., 2014). Accordingly, using
bioinformatic approaches, we previously predicted that a group of five uncharacterised
human secreted proteins and their Metazoan homologues, the FAM69/DIA1 family
(Aziz, Harrop & Bishop, 2011; Tennant-Eyles et al., 2011), are distant homologues of
protein kinases (Dudkiewicz, Lenart & Pawlowski, 2013). With the exception of the
pseudokinase DIA1R these proteins have well-conserved active site motifs and likely do
have kinase activity (Dudkiewicz, Lenart & Pawlowski, 2013).
According to the WiKinome classification (WiKinome, 2017), FAM69/DIA1 proteins
belong to Kinase Family RESK (REmote Secreted Kinases) that also contains the PKDCC
secretory kinase (Bordoli et al., 2014; Maddala, Skiba & Rao, 2016). The FAM69/DIA1
family is ubiquitous in Metazoa and is already present in sponges. The family has three
main branches (FAM69, DIA1 and PKDCC) that were probably present in the common
ancestor of Bilateria and Cnidaria (see Fig. 1).
Here, we focus on DIA1, which is one of few uncharacterised predicted secretory
kinases, and has been linked to autism (Morrow et al., 2008). The DIA1 protein (a.k.a.
C3orf58, HASF, GoPro49, PIP49) has been previously shown to reside in the Golgi
(Takatalo et al., 2008). DIA1 expression has been observed in cartilaginous mesenchymal
tissues, regulated developmentally, with the highest expression seen in proliferating
chondrocytes (Takatalo et al., 2008). Further, colocalisation with beta-coatomer protein
has been observed, and is suggestive of a function in secretory processes (Takatalo et al.,
2009). Then, characteristic expression of DIA1 has been observed in dental follicles, which
may also suggest a role in secretion and trafficking (Takatalo et al., 2009). However,
analysis of data deposited in the Allen Brain Atlas (Hawrylycz et al., 2012) indicates
that DIA1 is also expressed in the brain tissue, including the hippocampus, olfactory
bulb and cortex. Mass-spectrometry proteomic databases show relatively widespread
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expression of C3orf58 in the pancreas, adrenal gland, ovary and testis, lung, retina,
placenta and platelets (Kim et al., 2014; Wilhelm et al., 2014).
The DIA1 protein has to date been studied experimentally without reference to the
predicted kinase function. Evidence has been published for the role of DIA1 as a secreted
paracrine factor in PKCe-mediated cytoprotection (Beigi et al., 2013; Huang et al., 2014;
Miura, 2014), acting via interaction with the insulin-like growth factor 1 receptor (IGF1R)
(Bareja et al., 2017). As discussed further below, these extracellular functions are quite
intriguing, and may represent striking functional duality or growth-factor-like function
for a kinase-like molecule.
Many uncharacterised proteins are ignored by biologists due to a lack of known or
predicted molecular function (Pawlowski, 2008). Here, employing phosphoproteomics,
Figure 1 Phylogenetic tree of selected FAM69/DIA1 proteins. Colouring by taxonomy: red: verte-
brates, pink: echinoderms, magenta: sponges, yellow: molluscs, light green: nematodes, dark green:
cnidarians, blue: arthropods. Squares mark proteins predicted to be secreted, triangles—sequences with
an ‘EF-hand’ calcium ion-binding motif inserted into the kinase domain. Circles mark branches with
significant bootstrap values. Full-size DOI: 10.7717/peerj.4599/fig-1
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a promising approach to elucidate effects of uncharacterised kinases (Amano et al., 2015),
we present the first attempt to shed light on the molecular functions of one of the
members of the novel FAM69 protein family in the context of the predicted kinase
function. The main aims are to establish the secretory pathway localisation of DIA1 and to
investigate the effects of its presence on membrane fraction phosphoproteome.
First, we verified the presence of DIA1 in the endoplasmic reticulum (ER) and Golgi,
and using the RUSH system we provided evidence for a DIA1 role in secretory trafficking.
Next, the phosphoproteome of membrane fractions of DIA1-overexpressing cells was
compared with control cells with physiological levels of DIA1. We further investigated the
interactome of DIA1. Finally, we related the phosphoproteomics results to protein
functional relationship networks.
MATERIALS AND METHODS
Antibodies
The following antibodies were used: rabbit anti-calnexin (2679; Cell Signaling Technology,
Danvers, MA, USA), mouse anti-GM130 (610822; BD Biosciences, San Jose, CA, USA),
mouse anti-E-cadherin (HECD-1 clone, 13-1700; ThermoFisher Scientific, Waltham, MA,
USA), mouse anti-tubulin (T9026; Sigma-Aldrich, St. Louis, MO, USA), rabbit anti-histone 3
(H0164; Sigma-Aldrich, St. Louis, MO, USA), rabbit anti-DIA1/C3orf58 (ab103202; Abcam,
Cambridge, UK), rat anti-HA (11867423001; Applied Science, Penzberg, Germany), anti-
mouse, anti-rabbit, anti-rat antibodies conjugated with Alexa Fluor (Invitrogen, Carlsbad,
CA, USA) or horseradish peroxidase (Jackson ImmunoResearch, West Grove, PA, USA).
Plasmids
Plasmid encoding human DIA1 cDNAwas purchased from Source BioScience LifeSciences
(IRAT Clone c3orf58; Nottingham, UK). pcDNA3-2HA plasmid was constructed based
on pcDNA3 (ThermoFisher Scientific, Waltham, MA, USA) by inserting two repetitions
of the HA sequence downstream of the multicloning site (a kind gift from Dr. Iwona
Cymerman). pcDNA3Dia1HA was generated by subcloning PCR amplified human
c3orf58 cDNA using IRAT Clone c3orf58 as a template to BamHI/EcoRI sites of
pcDNA3-2HA. Str-li_VSVGwt-SBP-EGFP plasmid (a kind gift from Dr. Franck Perez,
Boncompain et al., 2012; Addgene plasmid # 65300).
In vitro cell line culture and transfection
HEK293T cells (ATCC, Manassas, VA, USA) and HeLa cells (Sigma-Aldrich, St. Louis,
MO, USA) were grown under standard culture conditions (Swiech et al., 2011; Perycz et al.,
2011). The cells were transfected using polyethylenimine (23966; Polysciences, Inc.,
Warrington, PA, USA) 24–48 h before any further analysis.
Cell fractionation
Qproteome Cell Compartment kit (Qiagen, Redwood City, CA, USA) was used for
subcellular fractionation. The collected fractions were analysed by standard Western blot
protocol or by mass spectrometry.
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Live-cell imaging and image analysis
Twenty-four hours after transfection, HeLa cells growing on glass coverslips were
transferred into a low profile open bath chamber (RC-41LP; Warner Instruments,
Hamden, CT, USA) filled with culture media. At time 0, D-biotin (40 mM final
concentration; Sigma-Aldrich, St. Louis, MO, USA) was added to cells. The time-lapse
acquisition was performed at 37 C and 5% CO2 atmosphere using spinning-disk
microscope (Andor Revolutions XD, Belfast, UK) equipped with 63 oil objective and a
thermostat-controlled chamber. Cell images were acquired as Z-stacks once per minute
for 1 h at 1,004  1,002 pixel resolution and next converted using a maximum intensity
projection function. For all the scans, microscope settings were kept the same. Image
analysis was conducted with ImageJ software (National Institutes of Health, Bethesda,
MD, USA). Time-lapse images were aligned with the StackReg plug-in for ImageJ
(Thevenaz, Ruttimann & Unser, 1998). Next, three different regions of interest of the same
size comprising the Golgi complex (the position of the Golgi complex was obtained using
later time points) were selected and the total fluorescence intensity was measured for each
time point using the Time Series Analyzer V3 plug-in for ImageJ and normalised to the
maximum value (1). To assess statistical significance, the Mann–Whitney test was used.
Immunofluorescence and imaging of immunofluorescently
stained cells
For immunofluorescence staining, HeLa cells were fixed and immunofluorescently
stained as described (Swiech et al., 2011). Images of stained cells were obtained using a
Zeiss NLO 710 confocal microscope with a 40 oil objective (1,024  1,024 pixel
resolution) as Z-stacks of the images (averaged twice per line) and next converted to single
images with a maximum intensity projection function.
Immunoprecipitation
Twenty microliters of Pierce anti-HA Magnetic Beads (ThermoFisher Scientific, Waltham,
MA, USA) were rinsed with lysis buffer (150 mM KCl, 20 mM HEPES–NaOH (pH 7.5),
0.3% CHAPS, protease and phosphatase inhibitors). Beads were incubated with cell lysate
(800 ml, obtained from four million cells) from DIA1-HA expressing cells and from control
cells for 45 min at 4 C, and next were washed three times using 300 mM NaCl, 0.1%
CHAPS, 20 mM HEPES–NaOH, pH 7.5 and finally resuspended in 25 mM HEPES
(pH 7.5), 1 mMMnCl2, 10 mMMgCl2, 1 mM CaCl2, and 50 mM KCl. The experiment was
repeated twice in pH 5 and twice in pH 7, thus four DIA1 and four control samples were
available for liquid chromatography–tandemmass spectrometry (LC-MS/MS) experiments.
Proteomic sample preparation
For protein extraction, the methanol/chloroform method was used (Wessel & Flugge,
1984). Pellets were diluted in 6 ml 15% sodium deoxycholate and then 100 mMNH4HCO3
was added to obtain a final volume of 86 ml. TCEP (0.5 M) was added to a sample for a
final concentration of 5 mM and incubated at 60 C for 1 h. To block reduced cysteine
residues, 200 mMMMTS at a final concentration of 10 mMwas added and the sample was
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subjected to incubation at room temperature for 10 min. For digestion, trypsin
(Promega, Madison, WI, USA) was added at a 1:20 v/v ratio and the sample was incubated
at 37 C overnight. Finally, trifluoroacetic acid was used to inactivate trypsin and remove
sodium deoxycholate. Resulting peptides were analysed by LC-MS/MS for peptide
identification or phosphopeptide enrichment.
Phosphopeptide enrichment with Ti-IMAC
For phosphopeptide enrichment, MagReSyn Ti-IMAC was used according to the
Ti-IMAC manufacturer’s protocol.
LC-MS/MS settings
Liquid chromatography–tandem mass spectrometry proteomic analyses of samples were
performed with an LTQ-Orbitrap Elite mass spectrometer (ThermoFisher Scientific,
Waltham, MA, USA) coupled with a nanoACQUITY (Waters Corporation, Milford, MA,
USA) UPLC system. Measurements were conducted in positive polarity mode, with
capillary voltage set to 2.5 kV. A sample was initially applied to the nanoACQUITY UPLC
Trapping Column (Waters) while water containing 0.1% formic acid was used as a mobile
phase. Then, the peptide mixture was transferred to a nanoACQUITY UPLC BEH C18
Column (75 mm inner diameter; 250 mm long; Waters), applying an acetonitrile gradient
(5–35% acetonitrile over 160 min) in the presence of 0.1% formic acid with a flow rate of
250 nl/min. Peptides were eluted directly to the ion source of the mass spectrometer.
Before each LC run, a blank run was performed to ensure no material was carried-over
from a previous analysis.
Higher-energy Collisional Dissociation (HCD) fragmentation was applied. Up to
10 MS/MS events were allowed per MS scan. See the Supplemental Information for
additional MS analysis parameters.
Qualitative MS data processing and database search
The raw data files acquired by MS and MS/MS were processed using MaxQuant
software (version 1.5.8.3). The ion lists were searched against the SwissProt human
database (20,274 sequences) using the Andromeda search engine (Cox et al., 2011).
The search parameters were set as follows: enzyme—trypsin; fixed modifications—
cysteine modification by MMTS; variable modifications—oxidation of methionine,
phosphorylation of serine, threonine and tyrosine. Peptide mass tolerance was set to
40 ppm for recalibration and 5 ppm for the main search. The ‘match between runs’ option
was used to transfer identifications to other LC-MS runs based on their masses and
retention time with a maximum deviation of 0.7 min. Both proteins and peptides were
identified with a false discovery rate (FDR) of 1%. The MaxQuant label-free algorithm
was used for protein quantification in non-phospho-enriched samples.
Proteomics data
The mass spectrometry proteomics data have been deposited with the ProteomeXchange
Consortium via the PRIDE (Vizcaino et al., 2016) partner repository with the dataset
identifier PXD006831.
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Bioinformatics
Statistical analysis of differences in proteome and phosphorylation state between six WT
and six DIA1-transfected samples was performed in Perseus software (version 1.5.8.5)
(Tyanova et al. 2016). MaxLFQ intensities of protein groups in non-phospho-enriched
experiments and phosphosite intensities in enriched samples were further processed
excluding peptide matches from decoy and contaminant databases. Additionally, for
phospho-enriched samples, intensities of phosphorylation sites were subjected to statistical
analysis if the localisation probability exceed 75%. For non-enriched membrane samples,
proteins identified only by modification site were deleted from analysis. All values for each
replicate were log2 transformed and normalised by median subtraction. Quantitative
analysis was performed using the t-test with permutation-based FDR correction only for
PTM sites or proteins identified in at least four out of six replicates in each group. Those
differences with a FDR q-value less than 0.05 were considered statistically significant. Also,
hits were selected as qualitative changes, if they were quantified in at least four samples of
the six samples in one group and not detected in the other sample set.
For analysis of DIA1 interactors, four replicates from control and DIA1 groups were
compared using the t-test in a similar manner as for non-phospho-enriched samples.
In the interactome analysis, protein groups were subjected to quantitative analysis with
the t-test if they were quantified in at least three samples in each group. Also, proteins were
considered to significantly differ in abundance qualitatively, if they were quantified in at
least three samples out of four in one group and not detected in the other sample set.
Functional analysis of lists of proteins was performed using the DAVID and Panther
servers (Huang, Sherman & Lempicki, 2009;Mi et al., 2013). Overrepresentation of specific
functional annotations within the lists was determined by Fisher’s exact test as described
previously (Welinder et al., 2017). Gene Ontology annotations, SwissProt keywords,
and KEGG pathways were used as annotation terms for the enrichment analysis. For
lists of proteins with significantly changed expression, the background protein sets
consisted of all proteins detected. For visualisations, the Spotfire program was used
(Tibco Software, Inc., Palo Alto, CA, USA).
Further functional analysis of the regulated phosphoproteins was conducted using
Ingenuity Pathway Analysis (IPA) (Qiagen, Redwood City, CA, USA), in particular by
generating networks of protein–protein relationships. As background, the set of all
proteins detected in the experiment was used.
The KinomeXplorer toolset (Horn et al., 2014; Linding et al., 2008; Miller et al., 2008)
was applied to predict likely kinases causing the observed phosphorylation changes. Two
programs were used, NetPhorest, the atlas of consensus phosphorylation site sequence
motifs, and NetworKin, which adds protein interaction information to improve
NetPhorest predictions.
The PhosphoSitePlus database (Hornbeck et al., 2012, 2015) was used to relate the
observed phosphosites to literature findings.
The GibbsCluster-2.0 Server was applied for clustering of phosphosite sequences.
The regions surrounding the phosphorylated residue were considered (plus–minus three
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residues), and several desired numbers of clusters were tested (Andreatta, Alvarez &
Nielsen, 2017).
For the phylogenetic tree, homologues of human FAM69A-C, DIA1, DIA1R and
PKDCC proteins were identified for seven different taxonomy groups using classic
blastp searches and multiple sequence alignment was built using the Promals3D server
(Pei, Kim & Grishin, 2008). A maximum likelihood phylogenetic tree was constructed for
whole aligned sequences, with the aLRT statistical test for branch support using the
phyML method implemented in the phylogeny.fr server (Dereeper et al., 2008). EF-hand
motifs in analysed sequences were identified using the ScanProsite tool (Gattiker, Gasteiger
& Bairoch, 2002) while signal peptides were predicted using the SignalP program 3.0
(Bendtsen et al., 2004).
RESULTS AND DISCUSSION
Analysis of secretory traffic kinetics in DIA1-expressing living cells
Previous work has shown that DIA1 resides in Golgi but its functional role there has
not been analysed. Therefore, we decided to address the question of the potential role of
DIA1 in cargo trafficking via ER–Golgi apparatus to the plasma membrane. First,
however, we confirmed that DIA1 is indeed present in the secretory pathway. Toward this
end, HeLa cell line was transiently transfected with a DIA1-HA plasmid encoding DIA1
tagged on its C-terminus with a double HA tag and immunofluorescence staining was
performed for the HA tag and calnexin (an ER marker) and GM130 (a cis-Golgi marker).
As shown in Fig. 2A, in HeLa cells DIA1-HAwas mostly located in ER. Thus, we compared
synchronised trafficking of cargo in control and DIA1-overexpressing HeLa cells. We used
the RUSH system (Boncompain et al., 2012) using VSVG–EGFP as a reporter. This system
contains two major elements that need to be introduced to cells: (i) streptavidin fused
to resident ER protein (Ii; so called hook) and (ii) a reporter connected to streptavidin
binding peptide. In transfected cells, biotin treatment leads to release from the hook and
synchronised trafficking of the reporter (Boncompain et al., 2012). Thus, we tracked the
VSVG–EGFP trafficking in living cells within 60 min of biotin addition at time 0 (Fig. 2B).
Image analysis revealed that both in control and DIA1-expressing cells there was an
accumulation of VSVG–EGFP in the Golgi complex but dynamics of this process was
different (Fig. 2C). In DIA1-overexpressing cells the maximum accumulation in the Golgi
complex occurred 4 min faster than in the control (Fig. 2D). We also observed no
disturbances in reaching the plasma membrane for DIA1-overexpressing cells and control
cells. Nevertheless, the fraction of reporter protein accumulated in the Golgi complex at
20 min that reached the plasma membrane at 60 min was lower for Dia1-overexpressing
cells (Fig. 2E). The obtained results show that in HeLa cells, DIA1 is present in elements
of the secretory pathway (ER) and its increased abundance in the ER accelerates the
transition of secretory cargo from the ER to Golgi and slows down its release from this
compartment. A previous study by Takatalo et al. (2009) showed the presence of DIA1
primarily in Golgi, while Bareja et al. (2017) claimed DIA1 extracellular protein. These
findings are not necessarily contradictory and suggest that DIA1 is present through the
whole secretory pathway to be finally secreted. The observed differences likely reflect
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Figure 2 (A) Representative confocal images of HeLa cells transfected with pcDNA3Dia1HA and immunofluorescently stained for HA tag
(green), ER marker calnexin (red) and cis-Golgi marker GM130 (magenta). Cells were counterstained with Hoechst 33285 to visualise cell
nuclei. Inlets show zoomed in areas containing parts of ER and Golgi. Scale bar = 10mm. (B) Representative time-lapse confocal images of living HeLa
cells transfected with Str-li_VSVGwt-SBP-EGFP and DIA1-HAor pcDNA3 vector as a control, inwhich secretory trafficking of the fluorescent reporter
protein (VSVG–EGFP) was analysed using the RUSH system for 60 min after biotin addition (time 0). Scale bar = 10 mm. (C) Quantitative analysis of
the live imaging experiments performed as in (B). The plot shows VSVG–EGFP fluorescence intensity in the Golgi region at each time point nor-
malised to the maximum value. The data are expressed as mean for all analysed cells. Error bars indicate SEM. p < 0.01 (Mann–Whitney test).
Number of independent experimentsN = 3. Number of cells per variant (n): pcDNA3 (12), DIA1-HA (19). (D) Graph shows a comparison of VSVG–
EGFP maximum accumulation times in the Golgi area. The data are expressed as mean for all analysed cells. Error bars indicate SEM. p < 0.05
(Mann–Whitney test). Number of independent experiments and analysed cells per variant as in (C). (E) Graph shows a comparison of VSVG–EGFP
protein fractions accumulated in the Golgi complex (time = 20 min) that reached the plasma membrane at time = 60 min (expressed as t20–t60 min).
The data are expressed as mean for all analysed cells. Error bars indicate SEM. p < 0.05 (Mann–Whitney test). The number of independent
experiments and analysed cells per variant as in (C). (F) Representative images of Western blot analysis of HEK293T cell fractions from control cells
and cells transfected with DIA1-HA. GM130, E-cadherin served as a marker of the membrane fraction while alpha tubulin and histone 3 (H3) served as
markers of cytosolic and nuclear fractions, respectively (left panel). The fractionation experiment was repeated three times.
Full-size DOI: 10.7717/peerj.4599/fig-2
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differences between cell lines and constructs used in these studies. However, a question
arises as to how DIA1 affects secretory trafficking. Thus far, a biological function has been
assigned only to extracellular DIA1 (i.e. modulation of IGF1R activity; Bareja et al., 2017)
and one possibility is that DIA1 affects ER–Golgi–PM trafficking acting on IGFR1.
In fact, it has previously been shown that IGF-1 accelerates secretion of chromogranin
A via Arf1, an GTPase controlling Golgi trafficking (Mu¨nzberg et al., 2015). This would
explain why DIA1 affects not only ER–Golgi trafficking, but also cargo release from Golgi
(where it is less abundant in HeLa cells). On the other hand, as we show below, DIA1
interacts with many ER and Golgi proteins, and such interactions could be involved in the
regulation of cargo trafficking. In such case, intra- and extracellular functions of DIA1
would be different.
Phosphoproteome of membrane fraction of WT and DIA1-expressing
HEK293T cells
Because DIA1 is present in the secretory pathway and there potentially plays there a
functional role, we decided to compare phosphoproteomes of isolated membrane
fractions from control and DIA1-overexpressing HEK293T cells. We transiently
transfected cells with a DIA1-HA plasmid and performed cell fractionation. As shown in
Fig. 2F, the obtained fractions were relatively pure and DIA1-HA was present in the
fraction containing cellular membranes. It should be noted however, that in DIA1-
overexpressing HEK293T cells, DIA1-HA was also present in the nuclear fraction.
This may reflect differences between cell lines or it may stem from partial contamination
of nuclear fraction with the membrane fraction. Yet, in our opinion DIA1-HA presence
in nuclear fraction should not directly affect the phosphoproteomics analysis performed
on membrane proteins. After confirming the purity of the obtained membrane
fractions and effective overexpression of DIA1-HA, membranes from HEK293T cells,
control and overexpressing DIA1-HA were subjected to phosphoproteomic analysis.
Figure S1 shows heat maps of Pearson correlation coefficient and multiscatter plots
demonstrating the reproducibility of samples in proteome and phosphoproteome of
membrane fractions. By applying conservative proteomics criteria, 2,758 protein groups
(20,147 peptides, 563 phosphosites) were detected in the membrane fraction for the
control cells, and 2,265 protein groups (20,051 peptides, 620 phosphosites) in the
DIA1-HA overexpressing ones. After Ti-IMAC phosphopeptide enrichment, 2,030
protein groups (6,086 peptides, 2,752 phosphosites) were measured in the control cells,
and 1,770 protein groups (4,518 peptides, 2,757 phosphosites) in the DIA1-HA
overexpressing cells. The number of phosphorylated and non-phosphorylated proteins in
the membrane fraction and after Ti-IMAC phosphopeptide enrichment is illustrated in
Fig. S2. By merging the pre-enrichment and enriched result sets, 3,551 protein groups
were identified in the control cells and 2,534 in the DIA1-HA overexpressing ones. A total
of 3,764 protein groups were detected in 12 samples of the membrane fraction (six control
samples and six DIA1-HA samples), represented by 22,647 peptides with 6,921
phosphosites. A total of 1,920 phosphosites in phospho-enriched samples satisfied the
criterion of being quantified in at least four samples in both groups (DIA1 and WT).
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Additional information on the phosphosite statistics in enriched samples are provided in
the Supplemental Information file.
Assessment of changes in phosphopeptide abundance yielded 64 significantly changed
phosphosites in 56 proteins. Eight of the phosphosites on eight proteins were threonine
sites, and the rest—serine sites. The numbers of changed phosphosites are of the similar
order as in a recent paper studying phosphoproteomics of processes regulated by the
LRRK2 kinase (Steger et al., 2016). The majority of the changed phosphosites have
increased abundance in the DIA1-overexpressing cells (Fig. 3). The effects of DIA1
expression on phosphorylation are widespread, and many affected proteins are apparently
not in the secretory pathway, i.e. do not possess a signal peptide and are not annotated as
ER or Golgi proteins (Fig. 3). Thus, apparently DIA1 presence causes a widespread
response, likely due to signalling beyond its immediate cellular compartment.
In principle, an observed change in abundance of a phosphosite can be the result of
change in abundance of the given protein. To test whether this was not the case, we
examined the set of proteins whose abundance was significantly affected by DIA1. Indeed,
none of these proteins matched the set of proteins with changed phosphosites with the
only one obvious exception, DIA1 itself. According to the mass spectrometry analysis, in
DIA1-overexpressing cells the levels of this protein increased more than 2,000-fold.
Otherwise, only three other proteins had expression levels changed in response to DIA1
overexpression: Nucleolar transcription factor 1 (UBTF), 78 kDa glucose-regulated
protein (HSPA5) and pre-mRNA-splicing factor CWC22 (see Supplemental
Information). The two nuclear proteins, CWC22 and UBTF, were downregulated by DIA1
while the ER chaperone HSPA5 was upregulated. This suggests that some of the DIA1
functions in the secretory pathway may be exerted indirectly, by regulating the expression
of this chaperone. The set of proteins whose phosphorylation status was significantly
affected by DIA1 overexpression was subjected to the IPA system. IPA Core analysis
(Fig. 4) maps the query set of proteins onto a literature-derived network of protein
relationships and extracts subnetworks enriched in the query proteins. Thus, it can extract
functional modules enriched in a protein set. In the case of phosphoproteins dependent
on DIA1 expression, notable is the widespread effect, involving many nuclear proteins as
well as some cytoplasmic organelle and plasma membrane proteins (Fig. 4). On one hand,
it could be explained by the fact that the membrane fraction contains diverse membranes
besides Golgi and ER and some proteins can reside outside their prototypical cellular
location. For example several nuclear proteins, which we found in the membrane fraction
phosphoproteome, were previously reported not only in the nucleus but also in
membranous organelles called exosomes. Secondly, this observation may reflect the broad
cellular effects of DIA1. Finally, the biochemical fractionation never provides 100% pure
fractions and such ‘contaminations’ could be identified with such sensitive method as
mass spectrometry. Here, for the set of phosphoproteins affected by DIA1 overexpression,
the top subnetworks were enriched in molecules involved in Cancer, Cell Morphology,
Cellular Assembly and Organization. In agreement with reported role of DIA1 in
stimulating cell cycle progression (Beigi et al., 2013), many of the network proteins are
involved in cell cycle (see Fig. 4).
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In the IPA analysis, among the general functional annotations overrepresented in the
query protein set, Cell Morphology, Cellular Assembly and Organization, and Cellular
Development were most significant. These changes in the cell phosphoproteome agree
with the proliferation and cell cycle effects of DIA1 observed by Dzau and co-workers in
cardiomyocytes (Beigi et al., 2013; Bareja et al., 2017).
An analysis of functional annotations overrepresented among proteins with
phosphosites affected by DIA1 expression was also performed using the Panther and
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Figure 3 Phosphosites affected by DIA1 expression. Difference WT-DIA1 (average signal intensity for
DIA1 vs. average intensity for WTsamples; y axis) plotted against t-test q-value (x axis). Data are in log2
scale: hence, difference of 1 corresponds to a two-fold change. (A) Red: phosphosites within proteins
annotated as ER or Golgi-resident. Filled squares: proteins possessing signal peptides. (B) Red: phos-
phosites predicted to be CK2 substrates. Yellow: phosphosites predicted to be CDK substrates.
Full-size DOI: 10.7717/peerj.4599/fig-3
Hareza et al. (2018), PeerJ, DOI 10.7717/peerj.4599 12/25
Figure 4 Ingenuity IPA analysis top subnetworks. Functional relationships between phosphoproteins
affected by DIA1 expression and tightly related proteins. Red: phosphoproteins with phosphosite abun-
dance increased upon DIA1 expression. Blue: phosphoproteins with phosphosite abundance decreased.
(A) First subnetwork in IPA analysis using direct and indirect relationships. (B) Merged subnetworks 1, 2
and 3 in IPA analysis using only direct relationships. Proteins related to cell cycle marked.
Full-size DOI: 10.7717/peerj.4599/fig-4
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DAVID servers. The conclusions provided by the two servers were similar: namely, very
few overrepresented functional annotations were assigned to the query protein set, which
highlights the diversity of the processes affected by DIA1 expression.
The local sequence motifs surrounding the phosphosites affected by DIA1 expression
were submitted to the GibbsCluster server to elucidate the most common motifs. The
DIA1-dependent phosphosites were clearly grouped into two distinct sequence clusters:
25 sites resembled the S[DE], Sx[DE] or Sxx[DE] consensus reminiscent of the CK2 site,
while 29 phosphosites (see Fig. 5) matched the [ST]P consensus reminiscent of
proline-directed kinases, for example CDK family, MAPK family and GSK3. Clearly,
precise assigning the changed phosphosites to particular kinases and elucidating
kinase-specific substrate motifs is challenging and may require specific tools as specific
inhibitors or knock-out mice (Steger et al., 2016) that are not readily available for a novel
poorly studied kinase-like protein such as DIA1. In order to attempt mapping of the
differential phosphosites to known kinase substrate sites, the KinomeXplorer server was
used. Notably, both prediction tools (NetworKin and NetPhorest) predicted that a
substantial number of affected sites are putative CK2 sites (see Fig. 3B). Also, the sites
predicted as CK2-like obtained higher confidence scores than the other sites. However,
it has to be noted that the challenging task of assigning phosphosites to kinases is difficult
because the datasets and tools available may be biased towards common motifs and
well-studied kinases.
The DIA1 protein itself is found to be phosphorylated on five residues, S124, S191,
S378, S387 and S426, none of which can be found in the PhosphositePlus database, where
this protein is shown to be phosphorylated on four other sites: S13, Y92, Y96 and Y183.
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Figure 5 Sequence logos for phosphosites affected by DIA1 expression (GibbsCluster results). (A, C)
CK2-like sites; (B, D) proline-directed kinase sites. (A, B) Sites upregulated in DIA1-overexpressing cells.
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The functional role of phosphorylation on S124, S191, S378, S387 and S426 is not clear,
although three of these residues (S124, 387 and 426) are not conserved evolutionarily in
DIA1 homologues, and therefore may be not important in the regulation of DIA1
function. Also, some of these sites occur in DIA1 regions for which structure prediction
is difficult. S124 and S191 are located in the kinase N-lobe, in a region corresponding to
Ca2+-binding EF-hand motif insertion seen in FAM69A and FAM69B. S124 is part of a
QSIC motif, where it can be speculated that phosphorylation affects the disulfide-bonding
capability of the cysteine C125, and in consequence, the relative arrangement of the N- and
C-lobes of the kinase domain. The S378, S387 and S426 are located in alpha-helical regions
of the C-terminal lobe, likely far from the predicted catalytic site. Considering the spatial
relation to the predicted active site, the two conserved phosphosites in DIA1 (S191 and
S378) are more likely to affect interactions with binding partners (e.g. substrates) than
catalysis itself. However, it is not completely unlikely that phosphorylation, possibly
coupled with disulfide formation by some of the highly conserved Cys residues
(Dudkiewicz, Lenart & Pawlowski, 2013), regulates DIA1 kinase activity.
A number of phosphosites affected by the presence of DIA1 occurred in proteins
located in the ER or Golgi or otherwise related to the secretory pathway and were subject
to further scrutiny.
Interactome of DIA1
In this complementary analysis, we wanted to find potential DIA1-interacting proteins.
Thus eluates from beads exposed to extracts from DIA1-HA-expressing HEK293T cells
(four samples) were compared by LC-MS/MS proteomics with those from control
cells (four samples). In total, 265 protein groups were measured in the eluates as being
present in at least three samples in each group, and a t-test showed that 16 proteins were
likely DIA1 binders. A further seven proteins were likely DIA1 binders since they were
detected in at least three DIA1 samples and absent from all control samples. Of these
23 proteins, only three proteins were also identified as having phosphorylation status
dependent on DIA1 presence: ARL6IP4, YBX1 and SRRM2. These may be considered
potential substrates, if DIA1 is indeed proven to be a functional kinase. However, such a
conclusion is speculative at this stage, because these are mostly nuclear proteins unlikely
to interact with DIA1 directly and also because they have very diverse phosphosites
(SxxE, SE and SP, respectively, see Table 1). Notably, this may also reflect that upon
overexpression of DIA1-HA in HEK cells, some overexpressed protein could be found in
the nuclear fraction and act there. Of the potential DIA1 interactors, 11 also had Golgi or
ER localisation, including GIGYF2 (GRB10-interacting GYF protein 2), SEC61B (protein
transport protein Sec61 subunit beta), and LRRC59 (leucine-rich repeat-containing
protein 59). The latter 11 proteins may be considered likely physiological interactors
of DIA1 and may be together involved in regulation of cargo trafficking.
Selected DIA1-affected phosphoproteins
Given the secretory pathway localisation of DIA1, it is noteworthy that a number of
proteins with phosphosites affected by different levels of DIA1 are located in the Golgi and
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Table 1 Selected phosphosites observed in this study as being dependent on DIA1 presence and related to the secretory pathway or otherwise
related to the predicted DIA1 kinase activity.
Protein
ID
Protein name Gene
name
Phosphosite
motif
Phosphosite
position
Student’s
T-test
p-value
DIA_WT
Student’s
T-test
q-value
DIA_WT
DIA1
vs.
WT FC
Localisation
Q9H0W5 Coiled-coil domain-
containing protein 8
CCDC8 PQASPRR 261 NA NA UP Cytoskeleton,
cytoplasm
Q59H18 Serine/threonine-protein
kinase TNNI3K
TNNI3K EVFTQCT 637 NA NA UP Nucleus, cytoplasm
Q9H307 Pinin PNN QQDSQPE 381 0.0004 0.028 3.7 Nucleus
Q9NR31 GTP-binding protein
SAR1a
SAR1A IDRTDAI 139 0.0018 0.045 2.1 ER/Golgi
Q9H8Y8 Golgi reassembly-stacking
protein 2
GORASP2 MAGTPIT 222 0.0014 0.038 2.0 Golgi
Q66PJ3 ADP-ribosylation factor-
like protein 6-interacting
protein 4
ARL6IP4 WHRSAGE 332 0.0001 0.024 1.97 Nucleus; DIA1
interactor
P0DMV9 Heat shock 70 kDa
protein 1B
HSPA1B KGGSGSG 631 0.0014 0.039 2.0 Nucleus, cytoplasm, ER
Q8TB61 Adenosine 3′-phospho 5′-
phosphosulfate
transporter 1
SLC35B2 PVESPVQ 427 0.0004 0.024 1.9 Golgi
Q8TDY2 RB1-inducible coiled-coil
protein 1
RB1CC1 RLDSLPE 222 0.0022 0.046 1.7 Cytoplasm, ER
P33981 Dual specificity protein
kinase TTK
TTK LLNSPDC 281 0.0008 0.039 1.6 Cytoskeleton
Q9H307 Pinin PNN RQESDPE 100 0.0003 0.048 1.6 Nucleus
Q8WVM8 Sec1 family domain-
containing protein 1
SCFD1 VENSPAG 303 0.0212 0.156 1.5 ER/Golgi
P27824 Calnexin CANX GTVSQEE 564 0.0310 0.179 1.49 ER
P53621 Coatomer subunit alpha COPA KNLSPGA 173 0.0037 0.058 1.5 Golgi
Q9NRX5 Serine incorporator 1 SERINC1 SDGSLED 364 0.0012 0.042 1.4 ER
Q14004 Cyclin-dependent
kinase 13
CDK13 GDVSPSP 383 0.0011 0.043 0.8 Nucleus, cytoplasm,
Golgi
Q56NI9 N-acetyltransferase
ESCO2
ESCO2 NQGSPFK 75 0.0010 0.041 0.6 Golgi, nucleus
O60238 BCL2/adenovirus E1B 19
kDa protein-interacting
protein 3-like
BNIP3L SSQSEEE 120 0.0021 0.046 0.53 Nucleus, ER,
mitochondrion
Q9UQ35 Serine/arginine repetitive
matrix protein 2
SRRM2 LSYSPVE 2694 0.0004 0.032 0.5 Nucleus; DIA1
interactor
P67809 Nuclease-sensitive
element-binding
protein 1
YBX1 NEGSESA 174 NA NA DOWN Nucleus, cytosol;
DIA1 interactor
Notes:
All these phosphosites (except the one in TNNI3K) are listed in the PhosphositePlus database. For comparative analysis of all phosphosites, see the Supplemental
Information. Note that for some phosphosites the t-test was not feasible due to their not being detected in one of the compared conditions (DIA1 or WT). Phosphosites
whose difference between DIA1 and WT was not strictly significant are shown in italics. Full results are provided as Supplemental Information.
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in the ER. One of these proteins (COPA) is annotated as involved in ER to Golgi
vesicle-mediated transport and also in the opposite process of retrograde vesicle-mediated
transport, Golgi to ER. DIA1 was previously shown to colocalise with related
beta-coatomer proteins (Takatalo et al., 2009).
When analysing proteins with phosphosites dependent on DIA1, we considered some
cases with borderline significance (t-test p-value < 0.05 and FDR q-value < 0.2) if the
proteins had ER or Golgi localisation. One such protein whose phosphorylation is
borderline affected by DIA1, calnexin (p-value 0.03, q-value 0.18), is a multifunctional
molecule, serving as a molecular chaperone of the ER (Chevet et al., 2010).
Phosphorylation at conserved sites (S534, S544) has been ascribed to CK2 and regulates
distribution of calnexin on ER (Chevet et al., 2010; Wong et al., 1998). Our results suggest
that calnexin phosphorylation at S534 and S544 may be regulated by DIA1.
Also, upon DIA1 expression, the phosphorylation of S303 in the SCFD1 (Sec1 family
domain-containing protein 1, Sly1p) borderline increases (p-value 0.02, q-value 0.16).
SCFD1 is involved in vesicle fusion, in the context of vesicular transport between the ER and
the Golgi (Demircioglu, Burkhardt & Fasshauer, 2014). Phosphorylation of S303, located on
the protein surface and away from the syntaxin binding site (Bracher & Weissenhorn, 2002),
may affect SCFD1 interactions with other elements of the vesicle fusion machinery.
Another protein where phosphorylation increased significantly in the presence of DIA1
is the GTP-binding protein SAR1A. This important component of the coat protein II
(COPII) is a trafficking protein that modulates membrane rigidity. SAR1A initiates
formation of COPII vesicles and thus regulates ER to Golgi transport (Brandizzi &
Barlowe, 2013; Loftus, Hsieh & Parthasarathy, 2012).
Further, phosphorylation of a phosphosite in GORASP2 (GRASP55) is increased upon
the presence of DIA1. GORASP2, known to be regulated by ERK, is required for Golgi
ribbon formation (Feinstein & Linstedt, 2008). The DIA1-dependent site (Thr222) has
been reported to be an ERK site (Vinke, Grieve & Rabouille, 2011). Interestingly,
GORASP2 is also involved in unconventional secretion, and this role is also
phosphorylation-dependent (Kim et al., 2016).
DIA1-overexpressing cells also feature increased phosphorylation of Serine
incorporator 1 (SERINC1), an ER serine transporter involved in membrane biogenesis
(Inuzuka, Hayakawa & Ingi, 2005). Our results show that in the presence of DIA1 changes
occur in phosphorylation of a number of proteins involved in the secretory pathway.
However, the diverse phosphorylation site motifs (see Table 1) suggest that the effects of
DIA1 on phosphorylation may be indirect.
Three of DIA1-dependent phosphoproteins are kinases, namely the CDK13 (cyclin-
dependent kinase 13), TNNI3K (serine/threonine-protein kinase TNNI3K) and TTK (dual
specificity protein kinase TTK). The relationships of these kinases with DIA1 are likely
indirect, however, because their localisation is not consistent with the localisation of DIA1.
The strong effect of the presence of DIA1 on CK2 phosphosites is interesting in the
context of CK2 roles in the development of the nervous system and its status as a
promising neurological drug target (Castello et al., 2017; Litchfield, 2003). However, it
cannot be ruled out that the observed changes in CK2 sites are partly due to activities of
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other kinases. The phosphosites of casein kinase 2 (CK2) and those of Golgi casein kinase
(FAM20C/G-CK) are rather similar (SxE and S/Txx[ED], respectively) (Tagliabracci et al.,
2014). Current bioinformatics tools and databases for phosphosite analysis (e.g.
KinomeXplorer) may not be able to distinguish between these two kinds of sites (Lasa-Benito
et al., 1996; Tibaldi et al., 2015). For example it has been shown that in the CK2-null cells only
less than one-third of ‘CK2’ phosphosites are significantly decreased (Franchin et al., 2017).
Therefore, our results do not allow the hypothetical direct phosphorylation by DIA1 to be
distinguished from its indirect effects, related or not to the hypothetical kinase activity.
Despite very strong evolutionary conservation of the predicted kinase active site in the
DIA1 family (Dudkiewicz, Lenart & Pawlowski, 2013), it cannot be excluded that DIA1
lacks enzymatic activity altogether, and is a pseudokinase, one of an emerging class of
kinase-like proteins with non-catalytic functions in cell signalling (Jacobsen & Murphy,
2017). Although DIA1 is the official the gene symbol for the Deleted in Autism 1, the gene
symbol DIA1 has also previously been used for two other human genes: DIAPH1
(diaphanous related formin 1) and CYB5R3 (cytochrome b5 reductase 3).
DIA1 has recently been characterised as a secreted paracrine factor and ligand for
IGF1R (Bareja et al., 2017). It has been found to promote cardiomyocyte regeneration via
PI3K kinase by stimulating proliferation and via PKCe by blocking apoptosis (Beigi et al.,
2013; Huang et al., 2014; Miura, 2014). These activities might occur via DIA1-mediated
phosphorylation of extracellular domains of IGF1R, and indeed the PhosphositePlus
database lists six such sites, although none was observed in this experiment. However,
DIA1 signalling via IGF1R might be independent of any kinase activity on its part.
The effects described by Dzau and co-workers and by us might be an effect of a
growth-factor-like function for a kinase-like protein.
The fact that no very strong effects of DIA1 expression on phosphopeptide abundance
are observed here may suggest that it is a pseudoenzyme. However, the strong
evolutionary conservation of the predicted active site suggests otherwise, and DIA1 may
require an as yet undiscovered activation mechanism to achieve its optimal enzymatic
capability. Further investigation into the molecular roles of this intriguing protein may
require massive effort combining phosphoproteomics, genetics and pharmacology in a
manner similar to the LRRK2 study (Steger et al., 2016) and may also require the inclusion
of other family members, namely FAM69A, B and C as well as DIA1R. If DIA1 is a
pseudokinase, then it may well act as a modulator of a related active kinase, similarly to
the FAM20C/FAM20A kinase/pseudokinase pair reported recently to act in the secretory
pathway (Cui et al., 2015).
CONCLUSION
Only one in five known phosphosites are mapped to a kinase. Moreover, the potential
regulatory functions of most phosphosites have not been revealed (Munk, Refsgaard &
Olsen, 2016; Munk et al., 2016).
Here, we have shown in an in vitro model that the expression of the predicted kinase
DIA1 is related to changes in many phosphosites in different cellular compartments.
Although direct and indirect effects of DIA1 could not be separated in this study, it is
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likely that DIA1 positively regulates CK2 signalling and also signalling by a proline-
directed kinase. It cannot be excluded that a different kinase with CK2-like consensus is
involved, or that DIA1 itself has a CK2-like substrate motif. Nevertheless, the kinase
activity of DIA1 still remains to be proven or disproven. The detailed elucidation of
enzymatic or other activities of DIA1 and its signalling network will require further
studies in different cellular systems.
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